Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: Increased local failure rate in nonresponders

Clinical Colorectal Cancer

Volumn 5, Issue 6, 2006, Pages 413-421

  Rengan, Ramesh ^a   Paty, Philip B ^a   Wong, W Douglas ^a   Guillem, Jose G ^a   Weiser, Martin ^a   Temple, Larissa ^a   Saltz, Leonard ^a   Minsky, Bruce D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Abdominoperitoneal resection; Radiation therapy; Sphincter function; Surgery

Indexed keywords

ATROPINE; DIPHENOXYLATE; FLUOROURACIL;

ADULT; AGED; ANUS SPHINCTER; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLOSTOMY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION DISORDER; DIARRHEA; DOSIMETRY; DYSURIA; ERYTHEMA; FATIGUE; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HUMAN; LYMPH NODE METASTASIS; MALE; NAUSEA; PREOPERATIVE CARE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RECTUM FISTULA; RECURRENT DISEASE; SALVAGE THERAPY; SURVIVAL RATE; TENESMUS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33646157059     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2006.n.012     Document Type: Article

References (67)

1. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 1997; 15:2030-2039.
2. Sauer R, Becker H, Hohenberger P, et al. Preoperative chemoradiotherapy as compared with postoperative chemoradiotherapy for locally advanced rectal cancer. New Engl J Med 2004; 351:11-20.
3. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control-final report of Intergroup 0114. J Clin Oncol 2002; 20:1744-1750.
4. Wagman R, Minsky BD, Cohen AM, et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 1998; 42:51-57.
5. Rengan R, Paty P, Wong WD, et al. Distal cT2N0 rectal cancer-is there an alternative to abdominoperineal resection? J Clin Oncol 2005; 23:4905-4912.
6. Baxter N, Morris AM, Rothenberger DA, et al. Impact of preoperative radiation for rectal cancer on subsquesnt lymph node evaluation: a population based analysis. Int J Radiat Oncol Biol Phys 2005; 61:426-431.
7. Minsky BD. Pelvic radiation therapy in rectal cancer: technical considerations. Sem Radiat Oncol 1993; 3:42-47.
8. Minsky BD, Kemeny N, Cohen AM, et al. Preoperative high-dose leucovorin/ 5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991; 67:2859-2866.
9. Minsky BD, Cohen AM, Enker WE, et al. Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 1993; 73:273-278.
10. Parks AG. Perianal anastomosis. World J Surg 1982; 6:531-538.
11. Pollett WG, Nicholls RJ. The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 1984; 198:159-163.
12. Minsky BD, Cohen AM, Enker WE, et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995; 31:553-559.
13. Ghadimi BM, Grade M, Difilppantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005; 23:1826-1838.
14. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 195 8; 5 3:457-481.
15. National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 1990; 264:1444-1450.
16. Bosset JF, Calais G, Mineur L, et al. Does the addition of chemotherapy (CT) to preoperative radiotherapy (preop RT) increase the pathological response in patients with resected rectal cancer; report of the 22921 EORTC phase III trial. Proc Am Soc Clin Oncol 2004; 23:247 (Abstract #3504).
17. Fakih M, Rajput A, Smith J, et al. A phase I study of weekly oxaliplatin and daily capecitabine and radiation therapy (RT) in locally advanced rectal cancer. Proc Am Soc Clin Oncol 2005; 2:190 (Abstract #213).
18. Gambacorta MA, Valentini V, Coco C, et al. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: phase I and II studies. Int J Radiat Oncol Biol Phys 2004; 60:139-148.
19. Mohiuddin M, Winter K, Mitchell E, et al. Results of RTOG-0012 randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer. Int J Radiat Oncol Biol Phys 2004; 60(suppl 1):138s-139s.
20. Rodel C, Grabenbauer GG, Papadopoulos T, et al. Phase I/II trial of capecitibine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003; 21:3098-3104.
21. De Paoli A, Chiara S, Luppi G, et al. A phase II study of capecitabine (CAP) and pre-operative radiation therapy (RT) in resectable, locally advanced rectal cancer (LARC). Proc Am Soc Clin Oncol 2004; 22:255 (Abstract #3540).
22. Fernandez-Martos C, Aparicio J, Bosch C, et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years follow-up. J Clin Oncol 2004; 22:3016-3022.
23. Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined modality therapy. Ann Surg Oncol 2003; 10:80-85.
24. Kuvshinoff B, Maghfoor I, Miedema B, et al. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < 1 cm distal margins sufficient? Ann Surg Oncol 2001; 8:163-169.
25. Beets-Tan RGH, Beets GL, Vliegen RFA, et al. Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 2001; 357:497-504.
26. Beets-Tan RGH, Beets GL. Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin? Int J Colorec Dis 2003; 18:385-391.
27. Branagan G, Chave H, Fuller C, et al. Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer? Dis Colon Rectum 2004; 47:1317-1322.
28. Bonnel C, Pare YR, Pocard M, et al. Effects of preoperative radiotherapy for primary resectable adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 2002; 45:934-939.
29. Dehni N, McNamara DA, Schlegel RD, et al. Clinical effects of preoperative radiation therapy on anorectal function after proctectomy and colonic J-pouch-anal anastomosis. Dis Colon Rectum 2002; 45:1635-1640.
30. Temple LK, Wong WD, Minsky B. The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Sem Radiat Oncol 2003; 13:469-477.
31. Nathanson DR, Espat NJ, Nash GM, et al. Evaluation of preoperative and postoperative radiotherapy on long-term functional results of straight coloanal anastomosis. Dis Colon Rectum 2003; 46:888-894.
32. Havenga K, Enker WE, McDermott K, et al. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996; 182:495-502.
33. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001; 49:987-995.
34. Rouanet P, Saint Aubert B, Lemanski C, et al. Restorative and nonrestorative surgery for low rectal cancer after high dose radiation. Long term oncologic and functional results. Dis Colon Rectum 2002; 45:305-315.
35. Hyams DM, Mamounas E, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Adjuvant Breast and Bowel Project protocol R-03. Dis Colon Rectum 1997; 40:131-139.
36. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17:2396-2402.
37. Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 2004; 22:2404-2409.
38. Maghfoor I, Wilkes J, Kuvshinoff B, et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer. Proc Am Soc Clin Oncol 1997; 16:274a (Abstract #971).
39. Valentini V, Coco C, Cellini N, et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998; 40:1067-1075.
40. Hiotis SP, Weber SM, Cohen AM, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002; 194:131-136.
41. Kahn H, Alexander A, Rakinic J, et al. Preoperative staging of irradiated rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound, and magnetic resonance imaging does not accurately predict TO, NO pathology. Dis Colon Rectum 1997; 40:140-144.
42. Gavioli M, Bagni A, Piccagli I, et al. Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer. Dis Colon Rectum 2000; 43:1075-1083.
43. Barbaro B, Schulsinger A, Valentini V, et al. The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 1999; 43:1043-1047.
44. Kuo LJ, Chern MC, Tsou MH, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005; 48:23-28.
45. Guillem JG, Moore HG, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 2004; 199:1-7.
46. Larson SM, Schoder H, Yeung H. Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer. Cancer J 2004; 10:243-250.
47. Katz MS, Minsky BD, Saltz LB, et al. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62:1363-1370.
48. Shia J, Guillem JG, Moore HG, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long term outcome. Am J Surg Path 2004; 28:215-223.
49. Wheeler JM, Dodds E, Warren BF, et al. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum 2005; 47:2025-2031.
50. Roedel C, Fietkau R, Raab R, et al. Tumor regression grading as a prognostic ractor in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Radiat Oncol Biol Phys 2004; 60(suppl 1):140s.
51. Vecchio FM, Valentini V, Minsky B, et al. The relationship of pathologic tumor regression grade (trg) and outcome after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62:752-760.
52. Luna-Perez P, Segura J, Alvarado I, et al. Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol 2000; 7:727-731.
53. Villafranca E, Okruzhnov Y, Dominguez MA, et al. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol 2001; 19:1779-1786.
54. Esposito G, Pucciarelli S, Alaggio R, et al. p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol 2001; 8:311-318.
55. Moore HG, Shia J, Klimstra DS, et al. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Ann Surg Oncol 2004; 11:955-961.
56. Saw RPM, Morgan M, Koorey D, et al. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Dis Colon Rectum 2003; 46:192-202.
57. Rodel C, Grabenbauer GG, Papadopoulos T, et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52:294-303.
58. Giralt J, Eraso A, Armengol M, et al. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54:1460-1465.
59. Giralt JL, Aranzazu E, Manuel D, et al. Prognostic significance of epidermal growth factor receptor (EGFR) in patients with rectal cancer treated with preoperative radiotherapy: a GICOR study. Int J Radiat Oncol Biol Phys 2002; 54(2 suppl 1):98-99.
60. Kandioler D, Zwrtek R, Ludwig C, et al. TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg 2002; 235:493-498.
61. Adell G, Zhang H, Jansson A, et al. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 2001; 50:659-663.
62. Grumann MM, Noack EM, Hoffman IA, et al. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001; 233:149-156.
63. Allal AS, Gervaz; P, Gertsch P, et al. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal study. Int J Radiat Oncol Biol Phys 2005; 61:1129-1135.
64. Schmidt CE, Bestmann B, Kuchler T, et al. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol 2005; 12:117-123.
65. Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high dose preoperative radiotherapy: the Lyon R96-02 randomized triaL J Clin Oncol 2004; 22:2404-2409.
66. Allal A, Pelloni A, Spataro V, et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results, and quality of life outcomes. Br J Cancer 2000; 82:1131-1137.
67. Feliu J, Calvillo J, Escribano A, et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 2002; 13:730-736.